MUFG Securities EMEA’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $470K | Buy |
+4,372
| New | +$470K | 0.59% | 37 |
|
|
2021
Q2 | – | Sell |
-1,049,318
| Closed | -$40.6M | – | 290 |
|
|
2021
Q1 | $40.6M | Buy |
1,049,318
+522,000
| +99% | +$20.2M | 0.33% | 61 |
|
|
2020
Q4 | $19M | Buy |
527,318
+274,000
| +108% | +$9.85M | 0.14% | 111 |
|
|
2020
Q3 | $9.68M | Sell |
253,318
-95,682
| -27% | -$3.66M | 0.09% | 135 |
|
|
2020
Q2 | $12.3M | Sell |
349,000
-231,750
| -40% | -$8.14M | 0.11% | 135 |
|
|
2020
Q1 | $19M | Buy |
580,750
+41,750
| +8% | +$1.36M | 0.19% | 93 |
|
|
2019
Q4 | $24.4M | Buy |
+539,000
| New | +$24.4M | 0.19% | 101 |
|
|
2018
Q4 | – | Sell |
-37,490
| Closed | -$1.44M | – | 415 |
|
|
2018
Q3 | $1.44M | Buy |
37,490
+35,944
| +2,325% | +$1.38M | 0.02% | 255 |
|
|
2018
Q2 | $51K | Buy |
+1,546
| New | +$51K | ﹤0.01% | 274 |
|